CD276 and neuroblastoma: Interestingly, miR-29a, which we show to be under-expressed in MNA tumors, was also recently shown to be down-regulated in neuroblastoma as it directly targets B7-H3, a cell surface immunomodulatory glycoprotein which contributes to the process of immune escape [18].